Your browser doesn't support javascript.
loading
'Bacteraemia with an MBL-producing Klebsiella pneumoniae: treatment and the potential role of cefiderocol heteroresistance'-authors' response.
Witt, Lucy S; Burd, Eileen M; Ozturk, Tugba; Satola, Sarah W; Weiss, David S; Jacob, Jesse T.
Affiliation
  • Witt LS; Department of Medicine, Division of Infectious Diseases, Emory University School of Medicine, Atlanta, GA 30322, USA.
  • Burd EM; Georgia Emerging Infections Program, Georgia Department of Public Health, Atlanta, GA 30303, USA.
  • Ozturk T; Department of Medicine, Division of Infectious Diseases, Emory University School of Medicine, Atlanta, GA 30322, USA.
  • Satola SW; Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA 30322, USA.
  • Weiss DS; Emory School of Medicine, Emory Antibiotic Resistance Center, Atlanta, GA 30322, USA.
  • Jacob JT; Emory School of Medicine, Emory Antibiotic Resistance Center, Atlanta, GA 30322, USA.
J Antimicrob Chemother ; 77(11): 3212, 2022 10 28.
Article in En | MEDLINE | ID: mdl-36177772

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Klebsiella Infections / Bacteremia Limits: Humans Language: En Journal: J Antimicrob Chemother Year: 2022 Document type: Article Affiliation country:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Klebsiella Infections / Bacteremia Limits: Humans Language: En Journal: J Antimicrob Chemother Year: 2022 Document type: Article Affiliation country: